Erectile dysfunction: Interrelationship with the metabolic syndrome

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Current Diabetes Reports

• Publication date

  2005-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/S11892-005-0070-8PMID 15663920
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of Erectile Dysfunction in Patients with Cardiovascular Disease

  2012cited by this paper
• Age-related increase in an advanced glycation end product in penile tissue

  2004cited by this paper
• Obesity and erectile dysfunction: common problems, common solution?

  2004cited by this paper
• Improvement in erectile function in men with organic erectile dysfunction by correction of elevated cholesterol levels: a clinical observation.

  2004cited by this paper
• Erectile dysfunction and cardiovascular disease.

  2004cited by this paper
• Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition

  2004cited by this paper
• Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial.

  2004cited by this paper
• Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition

  2004cited by this paper
• Relationship Between Erectile Dysfunction and Silent Myocardial Ischemia in Apparently Uncomplicated Type 2 Diabetic Patients

  2004cited by this paper
• Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator

  2003cited by this paper
• Relation of C-reactive protein and other cardiovascular risk factors to penile vascular disease in men with erectile dysfunction

  2003cited by this paper
• Relation of C-reactive protein and other cardiovascular risk factors to penile vascular disease in men with erectile dysfunction

  2003cited by this paper
• Sexual Function in Men Older Than 50 Years of Age: Results from the Health Professionals Follow-up Study

  2003cited by this paper
• New treatments for erectile dysfunction.

  2003influential reference
• American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of male sexual dysfunction: a couple's problem--2003 update.

  2003cited by this paper
• Novel cardiovascular risk factors and macrovascular and microvascular complications of diabetes.

  2003cited by this paper
• Accumulated endogenous NOS inhibitors, decreased NOS activity, and impaired cavernosal relaxation with ischemia.

  2002cited by this paper
• Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes.

  2002cited by this paper
• Impaired Nitric Oxide Synthase Pathway in Diabetes Mellitus: Role of Asymmetric Dimethylarginine and Dimethylarginine Dimethylaminohydrolase

  2002cited by this paper
• The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function

  2002cited by this paper
• Insulin resistance, ADMA levels, and cardiovascular disease.

  2002cited by this paper
• The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia.

  2002cited by this paper
• Sildenafil for male erectile dysfunction: a systematic review and meta-analysis.

  2002cited by this paper
• Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor.

  2002cited by this paper
• The efficacy of sildenafil citrate (Viagra) in clinical populations: an update.

  2002cited by this paper
• Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses.

  2002cited by this paper
• Etiology and treatment of erectile failure in diabetes mellitus

  2002cited by this paper
• Chronic exercise is associated with enhanced cutaneous blood flow in type 2 diabetes.

  2002cited by this paper
• Vascular response to stress in health and disease.

  2002cited by this paper
• Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome?

  2002cited by this paper
• Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

  2002cited by this paper
• Diabetes and endothelial dysfunction: a clinical perspective.

  2001cited by this paper
• Erectile and endothelial dysfunction in Type II diabetes: a possible link

  2001cited by this paper
• The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial

  2001cited by this paper
• Impairment of corpus cavernosal smooth muscle relaxation by glycosylated human haemoglobin

  2000cited by this paper
• Importance of asking questions about erectile dysfunction.

  2000cited by this paper
• Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk?

  2000cited by this paper
• Clinical Experience with Intraurethral Alprostadil (MUSE®) in the Treatment of Men with Erectile Dysfunction

  2000cited by this paper
• Erectile dysfunction.

  2000cited by this paper
• Clinical experience with intraurethral alprostadil (MUSE) in the treatment of men with erectile dysfunction. A retrospective study. Medicated urethral system for erection.

  2000cited by this paper
• Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure.

  2000cited by this paper
• Sexual function in men with diabetes type 2: association with glycemic control.

  2000cited by this paper
• Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee.

  1999cited by this paper
• Erectile dysfunction in the aging man.

  1999cited by this paper
• Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration.

  1998cited by this paper
• Hyperalgesia and decreased neuronal nitric oxide synthase in diabetic rats

  1998cited by this paper
• Effect of long-term passive smoking on erectile function and penile nitric oxide synthase in the rat.

  1997cited by this paper
• Does severity of ischemic coronary disease correlate with erectile function?

  1997cited by this paper
• Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS.

  1997cited by this paper
• Prevalence of Self-Reported Erectile Dysfunction in People With Long-Term IDDM

  1996influential reference
• Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study.

  1994cited by this paper
• Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction.

  1994cited by this paper
• NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence.

  1993cited by this paper
• The prevalence of diabetic impotence

  1980cited by this paper
• Writing Group Members

  year unknowncited by this paper

• Metabolic Syndrome-Associated Erectile Dysfunction: Multiple Vascular Endothelial Dysfunction Mechanisms and Potential Therapeutic Targets

  2025cites this paper
• Diagnostic work up: Laboratory and biomarkers.

  2022cites this paper
• PD22-12 COMPARATIVE STUDY OF RARP AND CARBON ION RADIOTHERAPY SEXUAL FUNCTIONAL CHANGES FOR PROSTATE CANCER USING THE PROPENSITY SCORE MATCHING METHOD

  2022cites this paper
• Identification of miRNA Signature Associated With Erectile Dysfunction in Type 2 Diabetes Mellitus by Support Vector Machine-Recursive Feature Elimination

  2021cites this paper
• Satisfaction of nutritionists who work in food service

  2019cites this paper
• Chapter 32 – Insulin Resistance and the Metabolic Syndrome

  2018cites this paper
• Serum Biomarkers of Erectile Dysfunction in Diabetes Mellitus: A Systematic Review of Current Literature.

  2017cites this paper
• Urine Derived Stem Cells for Potential Application in Treatment of Diabetic Erectile Dysfunction

  2017cites this paper
• Modulation of Dopaminergic Pathways to Treat Erectile Dysfunction.

  2016cites this paper
• The impact of poor glycaemic control on the prevalence of erectile dysfunction in men with type 2 diabetes mellitus: a systematic review

  2016cites this paper
• The effect of lifestyle modification and glycemic control on the efficiency of sildenafil citrate in patients with erectile dysfunction due to type-2 diabetes mellitus

  2015cites this paper
• Metabolic Syndrome Impairs Erectile Function

  2014cites this paper
• Circulating endothelial progenitor cells and endothelial microparticles in patients with arterial erectile dysfunction and metabolic syndrome.

  2012cites this paper
• Erectile dysfunction of vascular cause: statistical evaluation on the plurimetabolic syndrome's risk factors and their correlation with penile eco-doppler rates.

  2011cites this paper
• Erectile Dysfunction: A Disease Marker for Cardiovascular Disease

  2011cites this paper
• Erectile dysfunction of vascular cause: statistical evaluation on the Plurimetabolic Syndrome's risk factors and their correlation with penile eco-doppler rates.

  2011cites this paper
• Cardiovascular mortality in men with erectile dysfunction: increased risk but not inevitable.

  2011cites this paper
• Erectile dysfunction as a predictor for subsequent atherosclerotic cardiovascular events: findings from a linked-data study.

  2010cites this paper
• The burden and extent of comorbid conditions in patients with erectile dysfunction

  2009cites this paper
• Capítulo 35 - Resistencia a la insulina y el síndrome metabólico

  2009cites this paper
• Erectile dysfunction in diabetes mellitus.

  2009cites this paper
• Endothelial dysfunction as a commom link between erectile dysfunction and metabolic syndrome

  2009cites this paper
• Reversal of voltage-dependent erectile responses in the Zucker obese-diabetic rat by rosuvastatin-altered RhoA/Rho-kinase signaling.

  2009cites this paper
• Sexual Dysfunction and Cardiovascular Risk – Links and Solutions

  2009cites this paper
• Artigo de Revisão Bibliográfica Mestrado Integrado em Medicina ENDOTHELIAL DYSFUNCTION AS A COMMON LINK BETWEEN ERECTILE DYSFUNCTION AND METABOLIC SYNDROME

  2009cites this paper
• Markers of erectile dysfunction

  2008cites this paper
• NADPH Oxidase May be the Primary Mediator of Organic Erectile Dysfunction

  2008cites this paper
• Negative impact of metabolic syndrome on the responsiveness to sildenafil in Japanese men.

  2008cites this paper
• Metabolisches Syndrom und erektile Dysfunktion

  2007cites this paper
• Erectile dysfunction: a marker of early coronary heart disease.

  2007cites this paper
• Severity of erectile dysfunction in married impotent patients: Interrelationship with anthropometry, hormones, metabolic profiles and lifestyle

  2007cites this paper
• Sexual function and obesity

  2007cites this paper
• [Metabolic syndrome and erectile dysfunction. Epidemiologic associations and pathogenetic links].

  2007cites this paper
• Altered penile vascular reactivity and erection in the Zucker obese-diabetic rat.

  2007cites this paper
• Endothelial nitric oxide synthase as a mediator of the positive health effects of Mediterranean diets and wine against metabolic syndrome.

  2007cites this paper
• Are age, anthropometry and components of metabolic syndrome-risk factors interrelated with lower urinary tract symptoms in patients with erectile dysfunction? A prospective study.

  2007cites this paper
• Metabolic Risk Factors, Endothelial Dysfunction, and Erectile Dysfunction in Men With Diabetes

  2007cites this paper
• Erectile dysfunction as a predictor of the metabolic syndrome in aging men: results from the Massachusetts Male Aging Study.

  2006cites this paper
• Endogenous secretory RAGE as a potential biochemical screening tool for erectile dysfunction.

  2006cites this paper
• How a Primary Care Clinician Approaches Erectile Dysfunction

  2006cites this paper
• Would Montagnier please clarify whether HIV or oxidation by the risk factors is the primary cause of AIDS?

  2006influential citation
• A central role of eNOS in the protective effect of wine against metabolic syndrome

  2006cites this paper
• Sildenafil: efficacy, safety, tolerability and mechanism of action in treating erectile dysfunction

  2005cites this paper